{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:36Z","timestamp":1786119576611,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1,1]]},"DOI":"10.1097\/qai.0b013e3181fdc928","type":"journal-article","created":{"date-parts":[[2010,11,17]],"date-time":"2010-11-17T03:14:40Z","timestamp":1289963680000},"page":"83-90","source":"Crossref","is-referenced-by-count":18,"title":["Risk Factors Influencing Antibody Responses to Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Antigens in Patients Under Antiretroviral Therapy"],"prefix":"10.1097","volume":"56","author":[{"given":"Moraima","family":"Guadalupe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad H","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Westbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer","family":"Redding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Bullock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Anstead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K","family":"Agan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent C","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya","family":"Sankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Rebeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Flahive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Schoolfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linding","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufen","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Dow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ko","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J","family":"Infante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou-Jiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210131","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-0-387-46816-7_3","article-title":"Molecular biology of KSHV in relation to AIDS-associated oncogenesis.","volume":"133","author":"Greene","year":"2007","journal-title":"Cancer Treat Res"},{"key":"R2-13-20210131","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199607253350403","article-title":"Seroconversion to antibodies against Kaposis sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposis sarcoma.","volume":"335","author":"Gao","year":"1996","journal-title":"N Engl J Med"},{"key":"R3-13-20210131","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nm0896-925","article-title":"KSHV antibodies among Americans, Italians and Ugandans with and without Kaposis sarcoma.","volume":"2","author":"Gao","year":"1996","journal-title":"Nat Med"},{"key":"R4-13-20210131","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/nm0896-918","article-title":"The seroepidemiology of human herpesvirus 8 (Kaposis sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission.","volume":"2","author":"Kedes","year":"1996","journal-title":"Nat Med"},{"key":"R5-13-20210131","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJM199605163342003","article-title":"Antibodies to butyrate-inducible antigens of Kaposis sarcoma-associated herpesvirus in patients with HIV-1 infection.","volume":"334","author":"Miller","year":"1996","journal-title":"N Engl J Med"},{"key":"R6-13-20210131","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(96)07560-5","article-title":"Prevalence of Kaposis sarcoma- associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.","volume":"348","author":"Simpson","year":"1996","journal-title":"Lancet"},{"key":"R7-13-20210131","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(95)91619-9","article-title":"Detection of Kaposis sarcoma-associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposis sarcoma.","volume":"346","author":"Whitby","year":"1995","journal-title":"Lancet"},{"key":"R8-13-20210131","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00002030-199602000-00007","article-title":"Kaposis sarcoma-associated herpesvirus infection prior to onset of Kaposis sarcoma.","volume":"10","author":"Moore","year":"1996","journal-title":"AIDS"},{"key":"R9-13-20210131","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0140-6736(90)90001-L","article-title":"Kaposis sarcoma among persons with AIDS: a sexually transmitted infection?","volume":"335","author":"Beral","year":"1990","journal-title":"Lancet"},{"key":"R10-13-20210131","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0959-8049(99)00161-6","article-title":"Regression of AIDS-related Kaposis sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome.","volume":"35","author":"Cattelan","year":"1999","journal-title":"Eur J Cancer"},{"key":"R11-13-20210131","first-page":"44","article-title":"Acquired immunodeficiency syndrome-related Kaposis sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.","volume":"28","author":"Cattelan","year":"2001","journal-title":"J Natl Cancer Inst Monogr"},{"key":"R12-13-20210131","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/00002030-200308150-00015","article-title":"Detection and quantification of Kaposis sarcoma-associated herpesvirus to predict AIDS-associated Kaposis sarcoma.","volume":"17","author":"Engels","year":"2003","journal-title":"AIDS"},{"key":"R13-13-20210131","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/sj.bjc.6603100","article-title":"A prospective study of Kaposis sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.","volume":"94","author":"Newton","year":"2006","journal-title":"Br J Cancer"},{"key":"R14-13-20210131","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00002030-200402200-00015","article-title":"Short- and long-term effects of highly active antiretroviral therapy on Kaposis sarcoma-associated herpesvirus immune responses and viraemia.","volume":"18","author":"Bourboulia","year":"2004","journal-title":"AIDS"},{"key":"R15-13-20210131","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00126334-199912010-00003","article-title":"Human herpesvirus 8 (Kaposis sarcoma-associated herpesvirus) infection in men receiving treatment for HIV-1 infection.","volume":"22","author":"Campbell","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R16-13-20210131","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00002030-200301240-00012","article-title":"Risk factors for Kaposis sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus.","volume":"17","author":"Cannon","year":"2003","journal-title":"AIDS"},{"key":"R17-13-20210131","first-page":"779","article-title":"Long-term clinical outcome of AIDS-related Kaposis sarcoma during highly active antiretroviral therapy.","volume":"27","author":"Cattelan","year":"2005","journal-title":"Int J Oncol"},{"key":"R18-13-20210131","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.7855583","article-title":"AIDS-associated Kaposis sarcoma.","volume":"267","author":"Jones","year":"1995","journal-title":"Science"},{"key":"R19-13-20210131","first-page":"l101","article-title":"Anti-herpesvirus treatment and risk of Kaposis sarcoma in HIV infection. Royal Free\/Chelsea and Westminster Hospitals Collaborative Group.","volume":"10","author":"Mocroft","year":"1996","journal-title":"AIDS"},{"key":"R20-13-20210131","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199904083401402","article-title":"Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.","volume":"340","author":"Martin","year":"1999","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"R21-13-20210131","first-page":"S11","article-title":"Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Adult\/Adolescent Spectrum of HIV Disease Project Group.","volume":"21","author":"Jones","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R22-13-20210131","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00126334-200007010-00013","article-title":"Incidence and trends in Kaposis sarcoma in the era of effective antiretroviral therapy.","volume":"24","author":"Jones","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R23-13-20210131","doi-asserted-by":"crossref","first-page":"F45","DOI":"10.1097\/00002030-199807000-00002","article-title":"Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposis sarcoma.","volume":"12","author":"Lebbe","year":"1998","journal-title":"AIDS"},{"key":"R24-13-20210131","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1046\/j.0022-202x.2001.01465.x","article-title":"Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposis sarcoma to highly active antiretroviral therapy.","volume":"17","author":"Pellet","year":"2001","journal-title":"J Invest Dermatol"},{"key":"R25-13-20210131","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1086\/341088","article-title":"Prognostic value of quantitative Kaposis sarcoma-associated herpesvirus load in posttransplantation Kaposis sarcoma.","volume":"186","author":"Pellet","year":"2002","journal-title":"J Infect Dis"},{"key":"R26-13-20210131","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1056\/NEJMc070508","article-title":"HIV-associated Kaposis sarcoma with a high CD4 count and a low viral load.","volume":"357","author":"Maurer","year":"2007","journal-title":"N Engl J Med"},{"key":"R27-13-20210131","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1200\/JCO.2003.10.162","article-title":"AIDS-related Kaposis sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era-the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.","volume":"21","author":"Nasti","year":"2003","journal-title":"J Clin Oncol"},{"key":"R28-13-20210131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.clon.2007.09.004","article-title":"AIDS-related Kaposis sarcoma in a patient with a normal CD4 count.","volume":"20","author":"Power","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R29-13-20210131","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1128\/JCM.00191-06","article-title":"Use of a multiantigen detection algorithm for diagnosis of Kaposis sarcoma-associated herpesvirus infection.","volume":"44","author":"Laney","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R30-13-20210131","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1086\/515649","article-title":"Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group.","volume":"178","author":"Rabkin","year":"1998","journal-title":"J Infect Dis"},{"key":"R31-13-20210131","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1128\/JCM.38.6.2174-2180.2000","article-title":"Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection.","volume":"38","author":"Spira","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R32-13-20210131","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1086\/345866","article-title":"Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men.","volume":"187","author":"Biggar","year":"2003","journal-title":"J Infect Dis"},{"key":"R33-13-20210131","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.1128\/JVI.76.12.6185-6196.2002","article-title":"Efficient infection by a recombinant Kaposis sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis.","volume":"76","author":"Zhou","year":"2002","journal-title":"J Virol"},{"key":"R34-13-20210131","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S1047-2797(01)00242-3","article-title":"Seroprevalence of Kaposis sarcoma-associated herpesvirus infection among blood donors from Texas.","volume":"11","author":"Baillargeon","year":"2001","journal-title":"Ann Epidemiol"},{"key":"R35-13-20210131","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/jmv.21550","article-title":"Seroprevalence of Kaposis sarcoma-associated herpesvirus and risk factors in Xinjiang, China.","volume":"81","author":"Fu","year":"2009","journal-title":"J Med Virol"},{"key":"R36-13-20210131","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/jama.296.12.1498","article-title":"Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.","volume":"296","author":"Rodriguez","year":"2006","journal-title":"JAMA"},{"key":"R37-13-20210131","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/jmv.20949","article-title":"Seroreactivity to Kaposis sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposis sarcoma patients depends on CD4+ T-cell count.","volume":"79","author":"de Souza","year":"2007","journal-title":"J Med Virol"},{"key":"R38-13-20210131","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1128\/CDLI.8.5.913-921.2001","article-title":"Comparison of serologic assays for detection of antibodies against human herpesvirus 8.","volume":"8","author":"Corchero","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"R39-13-20210131","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/315039","article-title":"Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposis sarcoma.","volume":"180","author":"OBrien","year":"1999","journal-title":"J Infect Dis"},{"key":"R40-13-20210131","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980-2002.","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"key":"R41-13-20210131","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1086\/317650","article-title":"Distinct distribution of rare US genotypes of Kaposis sarcoma-associated herpesvirus (KSHV) in South Texas: implications for KSHV epidemiology.","volume":"183","author":"Zhang","year":"2001","journal-title":"J Infect Dis"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAI.0b013e3181fdc928","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:37:16Z","timestamp":1786041436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201101010-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181fdc928","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,1]]}}}